The Covid-19 pandemic is expected to continue to impose enormous burdens of morbidity and mortality while severely disrupting societies and economies worldwide.A vaccine provides the best hope for a permanent solution to controlling the pandemic. However, to be effective, a vaccine must be accepted and used by a large majority of the population. Aim:The aim of this study was to understand the acceptence and attitudes towards Covid-19 vaccination. Methodology: The current study used a cross-sectional design based on an online questionnaire. 944 responses were selected by non-probability snowball sampling technique The samples were including public of Udaipur district residents during the rapid rise period of the Covid-19 outbreak.An online structured questionnaire was developed by using Google forms, with a consent form appended to it. Three point likert scale (Agree, Not sure, and Disagree) consist of total 16 statements were prepared to assess attitude towards COVID-19 vaccination. Frequency and percentage distribution was used to present the data. Results:Resultsindicated that overall acceptance of Covid-19 vaccine in that majority of participant (N=750, Percentage=80.5%) would accept Covid-19 vaccine, whereas 3.4% particepant(N=32) would not accept Covid-19 vaccine and remaining 16.1% participants (N=152)were neutral to get vaccine.In addition, Male particepants(N=580) were more likely to accept Covid-19vaccines compared tofemalesparticepant (N=180).Majority of the participants (N=660, Precentage=69.9%) were agreed that the covid-19 vaccine is safe to receive, 64.4% respondents (N=608) were agreed that Covid-19 Vaccine undergoes enough safety and efficacy trial. Conclusion:It is concluded that acceptence towards covid-19 vaccination is high. They beleived that vaccine is safe and they will recommended to their family members also.Government effort should be made to fast distribute Covid-19 Vaccination.
Objective: To assess the determinants of out-of-pocket (OOP) expenses on diabetes-related treatment incurred in patients attending outpatient clinics in a tertiary care hospital in Delhi, India. Study Design: A cross-sectional analysis of baseline data from a quasi-experimental study was conducted over 8 months in 2016 in a major tertiary care hospital in Delhi. Methods: The study included 375 diabetes patients up to 65 years of age on treatment for at least a year without significant complications. Data were collected through a patient interview schedule. Results: Of the previous six scheduled appointments, at least two missed appointments were seen in 267 (71.2%) patients. The average patient's OOP expenditure on diabetes-related medicines was ₹63.5 a month, a similar amount was spent on traveling to and from health facilities. Sixty-four (17.1%) patients took antidiabetic medication for <85% of the days in the previous 3 months. Conclusion: There exists a high burden of missed clinic appointments among diabetes patients in tertiary care government health settings in India. This appears to be related to the high cost in terms of both time and money involved in attending appointments for the modest benefit of a dispensation of a 15-day drug refill. Health policy measures focused on strengthening medication coverage need to explore the balance of costs and benefits when determining the frequency of clinical appointments in these settings.
OBJECTIVE: To assess the determinants of out-of-pocket (OOP) expenses on diabetes-related treatment incurred in patients attending outpatient clinics in a tertiary care hospital in Delhi, India. STUDY DESIGN: A cross-sectional analysis of baseline data from a quasi-experimental study was conducted over 8 months in 2016 in a major tertiary care hospital in Delhi. METHODS: The study included 375 diabetes patients up to 65 years of age on treatment for at least a year without significant complications. Data were collected through a patient interview schedule. RESULTS: Of the previous six scheduled appointments, at least two missed appointments were seen in 267 (71.2%) patients. The average patient's OOP expenditure on diabetes-related medicines was ₹63.5 a month, a similar amount was spent on traveling to and from health facilities. Sixty-four (17.1%) patients took antidiabetic medication for <85% of the days in the previous 3 months. CONCLUSION: There exists a high burden of missed clinic appointments among diabetes patients in tertiary care government health settings in India. This appears to be related to the high cost in terms of both time and money involved in attending appointments for the modest benefit of a dispensation of a 15-day drug refill. Health policy measures focused on strengthening medication coverage need to explore the balance of costs and benefits when determining the frequency of clinical appointments in these settings.
